(Q42814099)

7 November 2017

Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2. (English)

1 reference

7 November 2017

0 references

1 reference

Jackson N

1

1 reference

7 November 2017

Lowe J

2

1 reference

7 November 2017

Ball J

3

1 reference

7 November 2017

Bromidge E

4

1 reference

7 November 2017

Ling NR

5

1 reference

7 November 2017

Larkins S

6

1 reference

7 November 2017

Griffith MJ

7

1 reference

7 November 2017

Franklin IM

8

1 reference

7 November 2017

1 January 1989

1 reference

Clinical and Experimental Immunology

7 November 2017

1 reference

7 November 2017

75

1 reference

7 November 2017

93-99

1 reference

7 November 2017

1

1 reference

describes a project that uses

7 November 2017

JJN-1

0 references

JJN-2

0 references

cites work

1 Preparation of monoclonal antibodies: Strategies and procedures

1 reference

12 December 2020

An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens

1 reference

12 December 2020

Chromosome abnormalities in chronic lymphocytic leukemia revealed by TPA as a mitogen

1 reference

12 December 2020

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

12 December 2020

Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells

1 reference

12 December 2020

The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis

1 reference

12 December 2020

Phenotypic and functional analysis of B cell lines from patients with multiple myeloma.

1 reference

12 December 2020

Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change

1 reference

12 December 2020

Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

1 reference

12 December 2020

Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.

1 reference

12 December 2020

A rapid banding technique for human chromosomes

1 reference

12 December 2020

Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture

1 reference

12 December 2020

A new characteristic karyotypic anomaly in lymphoproliferative disorders

1 reference

12 December 2020

Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation

1 reference

12 December 2020

Chromosome changes in human chronic lymphocytic leukemia

1 reference

12 December 2020

Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites

1 reference

12 December 2020

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

12 December 2020

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

12 December 2020

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

1 reference

12 December 2020

Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression

1 reference

12 December 2020

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

12 December 2020

Establishment and characterization of a permanent human IgA2/kappa myeloma cell line.

1 reference

12 December 2020

Human plasmacytoma with an unusual karyotype growing in vitro and producing light-chain immunoglobulin

1 reference

12 December 2020

Identifiers

1 reference